Now that we are under MSKCC’s care our disease evaluation regime is different to what it was in Sydney.
One of the biggest differences is that MSKCC do 4 sites for BM testing (2 in front + 2 in back) vs 2 sites (2 in back) like we did back home.
I discussed this with Dr. Kushner who said that he has seen quite a few cases where a relapse was detected in 1 out of 4 spots and only was in front.
I was wondering:
- What does your hospital do?
- Are there any papers that recommend 4 vs 2 sites?